Amgen, Horizon Say FTC Merger Challenge 'Defies Logic'

By Bryan Koenig · August 22, 2023, 9:01 PM EDT

Amgen and Horizon Therapeutics urged an Illinois federal judge not to let the Federal Trade Commission block their planned $27.8 billion merger, arguing in a brief unsealed Tuesday that FTC fears...

To view the full article, register now.

Documents

Case Information

Case Title

Federal Trade Commission V. Amgen Inc., et al.

Case Number

1:23-cv-03053

Court

Illinois Northern

Nature of Suit

410(Anti-Trust)

Date Filed

May 16, 2023